Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: '148 patent. Question
2
Oct 20, 2009 06:33PM
3
Oct 20, 2009 06:59PM
7
Oct 20, 2009 07:14PM
1
Oct 20, 2009 09:48PM
2
Oct 20, 2009 10:31PM

BaNosser , You kind of jarred my noggin. So, can running the re-exam process past the expiration of the patent allow a company to negate the treble charges even though the company was put on notice and knowingly infringed? That could be the strategy behind the re-examination of the re-examination of the re-examination. Interesting.

Share
New Message
Please login to post a reply